Roivant Sciences Ltd. (ROIV) stock analysis
ROIV · Roivant Sciences Ltd.
Latest recorded price: USD 38.61
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -46.9%, free cash flow margin -9,183.5%, ROIC -659.8%. The model flags 3 risk signals for this company (2 high severity).
Similar companies in Healthcare
- Royalty Pharma plc (RPRX)
- Revolution Medicines, Inc. (RVMD)
- Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX)
- Rhythm Pharmaceuticals, Inc. - Common Stock (RYTM)
- SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
- Summit Therapeutics Inc. (SMMT)
- Syndax Pharmaceuticals, Inc. (SNDX)
- Sarepta Therapeutics, Inc. (SRPT)